Core Laboratories (CLB) Misses Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- Lula, Brazil's iconic working class president, wins historic fourth term in dramatic comeback
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
- Accenture shares fall on insider sales and analyst downgrade
- Wall Street closes lower to end rocky week
- Credo Technology shares fall on competition concerns
Core Lab Reports First Quarter 2020 Results From Continuing Operations:
April 22, 2020 5:05 PM EDTAMSTERDAM, April 22, 2020 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations resulted in first quarter 2020 revenue of $152,400,000. The financial results for the first quarter of 2020 include a non-cash charge of $122,000,000 for the impairment of goodwill and intangible assets in the Production Enhancement segment, a charge of $1,000,000 associated with reductions in the workforce and other items. Core's operating loss was $(109,000,000), with a loss per diluted share ("EPS") of $(2.44), all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a... More



